A detailed history of Hobbs Group Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Hobbs Group Advisors, LLC holds 311 shares of BSX stock, worth $28,440. This represents 0.01% of its overall portfolio holdings.

Number of Shares
311
Previous 311 -0.0%
Holding current value
$28,440
Previous $24 Million 8.82%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$67.33 - $77.71 $4,107 - $4,740
61 Added 24.4%
311 $24 Million
Q4 2023

Feb 16, 2024

BUY
$48.64 - $57.81 $12,160 - $14,452
250 New
250 $14.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hobbs Group Advisors, LLC Portfolio

Follow Hobbs Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobbs Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobbs Group Advisors, LLC with notifications on news.